LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.0056667
 80.31 27.76 4356 6976 0.6244 0.8853
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 82.01 27.76 4583 7000 0.6547 0.8966
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 82.01 27.76 4601 7000 0.6573 0.8975
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 82.01 27.76 904 7000 0.1291 0.5474
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 82.01 27.76 4444 7000 0.6348 0.8893
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 83.72 27.76 4693 7055 0.6651 0.9005
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 83.72 27.76 4711 7055 0.6677 0.9014
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 83.72 27.76 1059 7055 0.1501 0.5774
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 83.72 27.76 4707 7055 0.6671 0.9012
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 85.42 27.76 4881 7025 0.6947 0.9108
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 85.42 27.76 4901 7025 0.6976 0.9118
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 85.42 27.76 1023 7025 0.1456 0.5711
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 85.42 27.76 4806 7025 0.6841 0.9071
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 87.13 27.76 5055 6987 0.7234 0.9204
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 87.13 27.76 5071 6987 0.7257 0.9212
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 87.13 27.76 1104 6987 0.1580 0.5869
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 87.13 27.76 5016 6987 0.7178 0.9186
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 88.84 27.76 5256 6965 0.7546 0.9306
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 88.84 27.76 5272 6965 0.7569 0.9313
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 88.84 27.76 1148 6965 0.1648 0.5952
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 88.84 27.76 5130 6965 0.7365 0.9247
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 90.55 27.76 5418 6928 0.7820 0.9392
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 90.55 27.76 5438 6928 0.7849 0.9401
MN20160318_Q01
I11
MCF 10A-H2B-mCherry Trametinib
0.0056667
 90.55 27.76 1267 6928 0.1829 0.6158
MN20160318_Q01
N13
MCF 10A-H2B-mCherry Trametinib
0.0056667
 90.55 27.76 5340 6928 0.7707 0.9357
MN20160318_Q01
N13